BioCentury
ARTICLE | Company News

Hetero Drugs sales and marketing update

July 11, 2016 7:00 AM UTC

Hetero launched Cizumab, a biosimilar of Avastin bevacizumab, in India to treat metastatic colorectal cancer (mCRC). Hetero said the maximum retail price is Rs28,450 ($418.22) for a 100 mg vial and R...